ARA-290 (Peptide) – Product Details

A peptide with great potential therapeutic possibilities, ARA-290 is well-known for its distinct qualities and how it has the potential to interact with the human body. The ARA-290 is centered on the special qualities and possible medical uses of this novel substance. It is a synthetic peptide with unique properties that distinguish it in the field of biomedical research. The naturally occurring glycoprotein hormone erythropoietin has long been known for its ability to increase the synthesis of red blood cells, and ARA-290, however, differs from its predecessor in that it places more emphasis on tissue protection and anti-inflammatory qualities. 

Take note that this article strictly serves an educational purpose, and under no circumstances should ARA-290 be considered safe for consumption without rigorous clinical evaluation and regulatory approval. Behemothlabz sells ARA-290 strictly for research purposes.

What is ARA-290 Peptide?

Created by Araim Pharmaceuticals, ARA-290 is a derivative of erythropoietin (EPO), a glycoprotein hormone recognized for its function in the generation of red blood cells. In contrast to EPO, ARA-290 concentrates on tissue preservation and anti-inflammatory qualities, creating additional opportunities for possible therapeutic purposes. [R]

ARA-290 emphasizes its distinction from traditional erythropoietin even further. Only 11 amino acids in length, this synthetic peptide is carefully designed from the sequence of EPO, preserving a shortened version that emphasizes its cytoprotective and anti-inflammatory properties. With this deliberate change, ARA-290 can potentially operate with a precision that surpasses that of its progenitor in navigating the intricate interactions of biological systems. [R] [R]

• CAS Number: 1208243-50-8
• Molar Mass: 1257.3 g/mol.
• Chemical Formula: C51H84N16O21
• Synonyms: ARA290; Cibinetide

Possible Applications of ARA-290

ARA-290 and Chronic Inflammatory Conditions

Chronic inflammatory conditions, characterized by persistent inflammation, often pose significant challenges in terms of disease management. ARA-290, distinguished by its anti-inflammatory properties, has emerged as a promising candidate for addressing these conditions. The study conducted by Brines et al. in 2008 focused on the peptide’s efficacy in modulating inflammatory responses, shedding light on its potential therapeutic applications. [R]

ARA-290’s ability to modulate inflammatory responses holds substantial implications for chronic inflammatory disorders such as rheumatoid arthritis and inflammatory bowel diseases. In these conditions, the immune system’s inflammatory response potentially becomes dysregulated, leading to prolonged inflammation and contributing to disease progression. [R]

ARA-290’s demonstrated capacity to modulate these responses suggests that it may play a pivotal role in mitigating the inflammatory cascade associated with these disorders.

ARA-290 and Neurological Disorders

An important direction for early study is the investigation of ARA-290’s neuroprotective potential in the context of neurological diseases, especially those that are marked by inflammation and cellular stress. The 2014 study by Ostrowski et al. has provided important new information about the peptide’s potential to defend against neuronal degeneration and damage, with potentially positive effects on neurodegenerative illnesses. [R] [R]

Neurological disorders are a broad category of illnesses where the development of neuronal damage is frequently aided by inflammation and cellular stress. The neuroprotective characteristics of ARA-290 become salient in this regard. The results of Ostrowski et al.’s study indicate that the peptide may be essential for protecting neurons from harm, providing a possible route for intervention in conditions characterized by neuronal degeneration. [R]

ARA-290 and Cardiovascular Health

Given ARA-290’s remarkable cytoprotective qualities, there is a strong case for further investigation into the peptide’s potential uses in cardiovascular health. The peptide’s potential to shield cardiac cells and reduce inflammation linked to cardiovascular disorders has been made clear by the important research done by Brines et al. in 2014. [R]

The cytoprotective qualities of ARA-290, as demonstrated by the study, make it a promising option for cardiovascular health therapies. The heart and blood vessels make up the cardiovascular system, which is vulnerable to a range of stresses and insults that can cause cellular damage. Given its capacity to shield cardiac cells, ARA-290 may play a part in maintaining the structural and functional integrity of the heart muscle, especially in times of illness or stress. [R]

The study’s main finding is that ARA-290 effectively lowers inflammation linked to cardiovascular illnesses. Heart failure and myocardial infarction are two cardiovascular diseases that are largely attributed to inflammatory processes. Because of ARA-290’s ability to control these inflammatory reactions, there is hope that the harmful consequences of excessive inflammation on the cardiovascular system may be lessened, thereby aiding in the prevention or treatment of cardiovascular illnesses.

ARA 290 and Tissue Regeneration and Repair

Researchers have looked into how ARA-290 may aid in tissue repair, especially when it comes to diabetic neuropathy. According to research done in 2012 by Brines et al., ARA-290 may be able to improve nerve regeneration and aid in functional recovery when tissue damage is present. The peptide presents itself as a promising compound for boosting tissue repair and regeneration in a variety of clinical circumstances due to its capacity to coordinate cellular responses to injury. [R]

Nerve injury is a frequent consequence of persistently elevated blood sugar in diabetic neuropathy. According to Brines et al.’s study, ARA-290 may promote nerve regeneration and hence provide therapeutic advantages for those with diabetic neuropathy. The peptide may have a significant impact on the restoration of injured tissues and the enhancement of functional results by modulating cellular responses to injury. This suggests that the peptide may have applications beyond neuropathy in tissue repair and regeneration. [R]

How Does ARA-290 Work?

The way that ARA-290 works in conjunction with the innate repair receptor (IRR) involves an intricate web of molecular processes that work together to provide anti-inflammatory and cellular defense mechanisms.

Engagement of the Innate Repair Receptor (IRR)

The innate repair receptor (IRR) is particularly bound by ARA-290 at the start of the process. One of the most important cell surface receptors in identifying and reacting to signals related to cellular stress and damage is the IRR. [R]

Opening of Signaling Channels

ARA-290 starts several intracellular signaling cascades when it binds to the IRR. Within the cell, these pathways function as a molecular communication network, sending signals that coordinate different cellular reactions. [R]

Cellular Protection

ARA-290 goes beyond its anti-inflammatory role and extends its influence to cellular protection mechanisms. This involves the regulation of apoptosis, a process of programmed cell death. By modulating apoptosis, ARA-290 can potentially prevent unnecessary cell death and promote cell survival in the face of stress or injury. [R]

Frequently Asked Questions (FAQs)

Can ARA-290 be used for self-treatment or without medical supervision?

No, ARA-290 is an experimental compound and is not approved for human consumption. It should only be used in the context of rigorous clinical trials under medical supervision. Self-treatment with ARA-290 is strongly discouraged.

Is ARA-290 available for public use or prescription?

As of now, ARA-290 is not available for public use or prescription. It is still under experimental investigation, and its potential therapeutic applications require further validation through extensive clinical trials.

How can I keep up with the most recent advancements in ARA-290 research?

Stay up-to-date with official announcements from research organizations, credible scientific journals, and medical databases by routinely monitoring them. Speaking with medical experts might provide you with more knowledge about where ARA-290 research is at the moment.

How does ARA-290 look for the future of medicine?

The outcomes of ongoing studies and clinical trials will determine ARA-290’s future prospects. It has the potential to transform therapies for a variety of ailments and open up new therapeutic options in the field of precision medicine if it is shown to be safe and effective.

Summary 

ARA-290 is an experimental compound derived from erythropoietin (EPO), designed with anti-inflammatory and cytoprotective properties. Originating from Araim Pharmaceuticals, ARA-290 departs from its progenitor to focus on tissue protection and repair. Studies suggest potential applications in chronic inflammatory conditions, neurological disorders, cardiovascular health, and tissue repair.

As an experimental substance, ARA-290 is not approved for human consumption, and its safety and efficacy await validation through rigorous clinical trials. The compound’s unique mechanisms and diverse potential uses make it a subject of keen interest in the evolving landscape of experimental therapeutics.

Why Buy ARA-290 From BehemothLabz?

BehemothLabz has established itself as a reliable and reputable source for research compounds and other chemicals since 2014. We take pride in offering the highest-quality products that are backed by independent, third-party-issued Certificates of Analysis for identification, purity, and concentration.

Our commitment to quality extends to every aspect of our business, from same-day processing to free shipping on all orders over $100 and our satisfaction guarantee.

At BehemothLabz, we understand the importance of accessing the best compounds for research purposes. Our team provides exceptional customer service and ensures that our customers have access to the compounds they need to conduct groundbreaking research.

We also offer international shipping to our customers around the world. Our team is committed to ensuring that your order arrives after research is needed to fully understand its mechanisms of action and potential applications in the treatment of various conditions.

BEHEMOTHLABZ DISCLAIMER

Please make sure you go through the Terms and Conditions and familiarize yourself with them as it is important. Please research the scientific uses of this product before making any purchases. Make note that the packaging and labels of the product may differ from those shown on the website.

Buying the product means you agree with our Terms and Conditions. You can contact our awesome customer service team at [email protected] if you are not fully satisfied with the product.

Customer satisfaction is our number one priority!

ATTENTION

All BehemothLabz products are strictly for LABORATORY AND RESEARCH PURPOSES ONLY. They are not to be used for any human or veterinary purposes.

Strength	16mg